Innate Pharma SA
PAR:IPH
During the last 3 months Innate Pharma SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 23% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/par/iph/vs/indx/gdaxi">open performance analysis).
The last transaction was made on
Jun 8, 2022
by
Herve Brailly
, who
sold
29.2k EUR
worth of
IPH shares.
During the last 3 months Innate Pharma SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 23% over this period ( loading = false, 5000)" href="https://new.alphaspread.com/comparison/par/iph/vs/indx/gdaxi">open performance analysis).
The last transaction was made on
Jun 8, 2022
by
Herve Brailly
, who
sold
29.2k EUR
worth of
IPH shares.
Innate Pharma SA
Glance View
Innate Pharma SA is a biopharmaceutical company, which engages in improving oncology treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. The company is headquartered in Marseille, Paca and currently employs 215 full-time employees. The company went IPO on 2006-10-31. The firm identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The firm develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The firm works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The firm operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.